Hedge fund manager and self-styled âÂÂshort activistâ Kyle Bass has been dealt another setback in his campaign to invalidate certain pharmaceutical patents.read more...
More from MoneyScience.
↧
Hayman's Bass Loses Second IPR Drug Patent Challenge
↧